Skip to main content
Top
Published in: World Journal of Surgery 5/2010

01-05-2010

Moving from Lymph Node Metastasis In Gastric Cancer to Biological Markers: Reply to Letter

Author: Naoto Fukuda

Published in: World Journal of Surgery | Issue 5/2010

Login to get access

Excerpt

Lymph node metastasis (pN category) and tumor depth invasion (pT category) have been the most important prognostic factors for patients with gastric cancer. In the pN category, although several studies [17] have clarified the prognostic significance of the metastatic lymph node ratio (MLR) in gastric cancer, it has not been widely used in clinical practice compared with the UICC/AJCC system commonly used in Western countries and the JGCA system commonly used in Japan. The MLR system has the advantage that it is independent of the number of dissected lymph nodes, which may be affected by the surgeon’s attitude toward lymph node dissection. Moreover, it is simple, convenient, and reproducible for predicting the prognosis as well as for treatment planning. Our study also revealed the superiority of the MLR for evaluating lymph node metastasis in patients with gastric cancer compared with the UICC/AJCC and JGCA systems, although the sample size of the study was small (n = 186). …
Literature
1.
go back to reference Nitti D, Marchet A, Olivieri M et al (2003) Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 10:1077–1085CrossRefPubMed Nitti D, Marchet A, Olivieri M et al (2003) Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 10:1077–1085CrossRefPubMed
2.
go back to reference Bando E, Yoneyama Y, Taniguchi K et al (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9:775–784CrossRefPubMed Bando E, Yoneyama Y, Taniguchi K et al (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9:775–784CrossRefPubMed
3.
go back to reference Inoue K, Nakane Y, Iiyama H et al (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27–34CrossRefPubMed Inoue K, Nakane Y, Iiyama H et al (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27–34CrossRefPubMed
4.
go back to reference Ozgüc H, Sönmer Y, Yerci O (2008) Metastatic/resected lymph nodes ratio-based classification in gastric cancer. Turk J Gastroenterol 19:2–7PubMed Ozgüc H, Sönmer Y, Yerci O (2008) Metastatic/resected lymph nodes ratio-based classification in gastric cancer. Turk J Gastroenterol 19:2–7PubMed
5.
go back to reference Saito H, Fukumoto Y, Osaki T et al (2008) Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol 97:132–135CrossRefPubMed Saito H, Fukumoto Y, Osaki T et al (2008) Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol 97:132–135CrossRefPubMed
6.
go back to reference Persiani R, Rausei S, Biondi A et al (2008) Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Eur J Surg Oncol 34:519–524PubMed Persiani R, Rausei S, Biondi A et al (2008) Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Eur J Surg Oncol 34:519–524PubMed
7.
go back to reference Huang CM, Lin BJ, Lu HS et al (2008) Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus. World J Gastroenterol 14:4383–4388CrossRefPubMed Huang CM, Lin BJ, Lu HS et al (2008) Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus. World J Gastroenterol 14:4383–4388CrossRefPubMed
8.
go back to reference Kobayashi M, Tsuburaya A, Nagata N et al (2006) A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer. Gastric Cancer 9:114–119CrossRefPubMed Kobayashi M, Tsuburaya A, Nagata N et al (2006) A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer. Gastric Cancer 9:114–119CrossRefPubMed
9.
go back to reference Kakeji Y, Oki E, Egashira A et al (2009) Phase study of biweekly docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Oncology 77:49–52CrossRefPubMed Kakeji Y, Oki E, Egashira A et al (2009) Phase study of biweekly docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Oncology 77:49–52CrossRefPubMed
10.
go back to reference Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820CrossRefPubMed Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820CrossRefPubMed
11.
go back to reference Roukos DH (2010) Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann Surg Oncol 17:14–17CrossRefPubMed Roukos DH (2010) Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann Surg Oncol 17:14–17CrossRefPubMed
Metadata
Title
Moving from Lymph Node Metastasis In Gastric Cancer to Biological Markers: Reply to Letter
Author
Naoto Fukuda
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 5/2010
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0461-0

Other articles of this Issue 5/2010

World Journal of Surgery 5/2010 Go to the issue